Q2 FY2026 EarningsQ2 FY26 revenue reached $594.8M, up 15.6% YoY and 4.3% QoQ, fueled by strong demand in Healthcare and Life Sciences (+22.0% YoY). Adjusted diluted EPS rose 22.3% YoY to $0.59, despite GAAP net income slightly declining to $64.5M due to increased stock-based compensation and acquisition-related expenses. Management raised FY26 revenue guidance to $2.39B–$2.415B (14%-16% YoY growth) and adjusted EPS to $2.25–$2.29, reflecting robust visibility in AI-driven data strategy execution.
Preview: EXLService(EXLS) predict that the Revenue is 594.76 M (+15.61%), Beat estimate;the EBIT is 87.3 M (+7.59%), Beat estimate;the EPS is 0.42 (+5%), Miss estimate.